These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15727597)

  • 1. Isolated urticaria to ondansetron and successful treatment with granisetron.
    Bousquet PJ; Co-Minh HB; Demoly P
    Allergy; 2005 Apr; 60(4):543-4. PubMed ID: 15727597
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous adverse drug reactions during chemotherapy: consider non-antineoplastic drugs.
    Bursztejn AC; Tréchot P; Cuny JF; Schmutz JL; Barbaud A
    Contact Dermatitis; 2008 Jun; 58(6):365-8. PubMed ID: 18503688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.
    Abali H; Celik I
    Cancer Invest; 2007; 25(3):135-9. PubMed ID: 17530482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blinded comparison of ondansetron, granisetron, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy.
    Jain V; Mitra JK; Rath GP; Prabhakar H; Bithal PK; Dash HH
    J Neurosurg Anesthesiol; 2009 Jul; 21(3):226-30. PubMed ID: 19543000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preemptive antiemesis in patients undergoing modified radical mastectomy: oral granisetron versus oral ondansetron in a double-blind, randomized, controlled study.
    Bhatnagar S; Gupta D; Mishra S; Srikanti M; Singh M; Arora R
    J Clin Anesth; 2007 Nov; 19(7):512-6. PubMed ID: 18063205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Goldsmith B
    Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-5-HT-3: a new group of antiemetics].
    Galindo JR
    Rev Clin Esp; 1996 Feb; 196(2):119-24. PubMed ID: 8685484
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
    Takenaka M; Okamoto Y; Ikeda K; Hashimoto R; Ueda T; Kurokawa N; Takagi T; Uejima E
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):403-7. PubMed ID: 17353632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
    Cheirsilpa A; Sinthusake T; Songsakkaesorn A; Visawaprasit S; Chulaka K; Changkuingdee N
    Jpn J Clin Oncol; 2005 Dec; 35(12):695-9. PubMed ID: 16319109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
    Hamadani M; Awab A; Chaudhary L; Tfayli A
    J Oncol Pharm Pract; 2006 Jun; 12(2):67-8. PubMed ID: 16984743
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia.
    Aapro M; Rabaeus M
    Am J Clin Oncol; 2005 Dec; 28(6):634-5. PubMed ID: 16317278
    [No Abstract]   [Full Text] [Related]  

  • 12. Anaphylaxis to an ondansetron wafer.
    Tan J; Mehr S
    J Paediatr Child Health; 2012 Jun; 48(6):543-4. PubMed ID: 21679335
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypersensitivity reactions associated with 5- hydroxytryptamine(3)-receptor antagonists: a class effect?
    Kataja V; de Bruijn KM
    Lancet; 1996 Mar; 347(9001):584-5. PubMed ID: 8596322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactic reaction to ondansetron.
    Weiss KS
    Arch Intern Med; 2001 Oct; 161(18):2263. PubMed ID: 11575988
    [No Abstract]   [Full Text] [Related]  

  • 15. Urticaria caused by dimenhydrinate.
    Paffumi I; Saitta S; Isola S; Gangemi S
    Allergol Immunopathol (Madr); 2012; 40(4):253-4. PubMed ID: 21889831
    [No Abstract]   [Full Text] [Related]  

  • 16. Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study.
    Shi Y; He X; Yang S; Ai B; Zhang C; Huang D; Dong M; Liu P; Zhou S; Han X
    Chemotherapy; 2007; 53(1):44-50. PubMed ID: 17202811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgE-mediated allergy to granisetron and safe use of ondansetron.
    Kanny G; Beaudouin E; Moneret-Vautrin DA
    J Allergy Clin Immunol; 2001 Dec; 108(6):1059-60. PubMed ID: 11742289
    [No Abstract]   [Full Text] [Related]  

  • 18. Generalised seizures following ondansetron.
    Sharma A; Raina V
    Ann Oncol; 2001 Jan; 12(1):131-2. PubMed ID: 11249042
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis.
    Neufeld SM; Newburn-Cook CV
    J Neurosurg Anesthesiol; 2007 Jan; 19(1):10-7. PubMed ID: 17198095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When prophylaxis fails: Is treatment of postoperative nausea and vomiting with same-class antiemetics useful?].
    Zaballos M; Agustí S; García de Lucas E
    Rev Esp Anestesiol Reanim; 2005; 52(6):377-8. PubMed ID: 16038184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.